Search Results

You are looking at 141 - 150 of 2,704 items for :

  • Refine by Access: All x
Clear All
Full access

Optimize Local Therapy for Oligometastatic and Oligoprogressive Non–Small Cell Lung Cancer to Enhance Survival

Joe Y. Chang and Vivek Verma

, metastasis; RT, radiotherapy; SABR, stereotactic ablative radiotherapy; SRS, stereotactic radiosurgery. For the purposes of this review, the definitions of oligometastasis and oligoprogression are based on adequate representation in existing randomized

Full access

The Role of Bridge Therapy Prior to Orthotopic Liver Transplantation

Meena A. Prasad and Laura M. Kulik

journal CE activity: 1) review the learning objectives and author disclosures; 2) study the education content; 3) take the posttest with a 66% minimum passing score and complete the evaluation at http://education.nccn.org/node/51010 ; and 4) view

Full access

Life After Treatment: Quality-of-Life Concerns in Patients Treated for Cancer

Mindy E. Goldman

a relevant hormonal marker of ovarian reserve. 1 Dr. Goldman briefly reviewed some of the common symptoms of menopause. “By far, hot flashes are the most common menopausal complaint, occurring in approximately 80% of women,” she noted. Moreover

Full access

Combined Modality Therapy of Esophageal Cancer

Rosalyn A. Juergens and Arlene Forastiere

Edited by Kerrin G. Robinson

for esophageal adenocarcinoma . N Engl J Med 1996 ; 335 : 462 – 467 . 30. Fiorica F Di Bona D Schepis F . Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis . Gut 2004 ; 53 : 925 – 930

Full access

Current Concepts in Penile Cancer

Philippe E. Spiess, Simon Horenblas, Lance C. Pagliaro, Matthew C. Biagioli, Juanita Crook, Peter E. Clark, Richard E. Greenberg, and Cesar E. Ercole

journal CE activity: 1) review the learning objectives and author disclosures; 2) study the education content; 3) take the posttest with a 70% minimum passing score and complete the evaluation at http://education.nccn.org/node/19339 ; and 4) view

Full access

BPI20-012: Relative Risk of Various Endocrinopathies Associated With the Use of Immune Checkpoint Inhibitors in the First-Line Treatment of Advanced Renal Cell Carcinoma: a Systematic Review and Meta-Analysis

Nusrat Jahan, Francis Mogollon-Duffo, Miguel Quirch, Somedeb Ball, Fred Hardwicke, Lukman Tijani, and Shabnam Rehman

Full access

NCCN Guidelines Insights: Hepatobiliary Cancers, Version 2.2019

Featured Updates to the NCCN Guidelines

Al B. Benson III, Michael I. D’Angelica, Daniel E. Abbott, Thomas A. Abrams, Steven R. Alberts, Daniel A. Anaya, Robert Anders, Chandrakanth Are, Daniel Brown, Daniel T. Chang, Jordan Cloyd, Anne M. Covey, William Hawkins, Renuka Iyer, Rojymon Jacob, Andreas Karachristos, R. Kate Kelley, Robin Kim, Manisha Palta, James O. Park, Vaibhav Sahai, Tracey Schefter, Jason K. Sicklick, Gagandeep Singh, Davendra Sohal, Stacey Stein, G. Gary Tian, Jean-Nicolas Vauthey, Alan P. Venook, Lydia J. Hammond, and Susan D. Darlow

.1 CEUs) of continuing education credit. UAN: JA4008196-0000-19-006-H01-P All clinicians completing this activity will be issued a certificate of participation. To participate in this journal CE activity: (1) review the educational content; (2) take the

Full access

Updates in the Systemic Therapy Options for Clear Cell and Non–Clear Cell Renal Cell Carcinoma

Presented by: Philippe E. Spiess, Peter A.S. Johnstone, and Eric Jonasch

chest computed tomography for renal cancer staging . BJU Int 2017 ; 120 : 490 – 496 . 27684653 2. Marconi L , Dabestani S , Lam TB , Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy

Full access

Radiation Therapy Modalities in Prostate Cancer

Thomas J. Pugh, Bao-Ngoc Nguyen, James E. Kanke, Jennifer L. Johnson, and Karen E. Hoffman

dose without parallel increases in toxicity, and have permitted exploration of altered radiation therapy fractionation schedules, such as hypofractionated treatment regimens, which shorten the overall duration of treatment. This article reviews these

Full access

Considerations for Use of Hematopoietic Growth Factors in Patients With Cancer Related to the COVID-19 Pandemic

Elizabeth A. Griffiths, Laura M. Alwan, Kimo Bachiashvili, Anna Brown, Rita Cool, Peter Curtin, Mark B. Geyer, Ivana Gojo, Avyakta Kallam, Wajih Z. Kidwai, Dwight D. Kloth, Eric H. Kraut, Gary H. Lyman, Sudipto Mukherjee, Lia E. Perez, Rachel P. Rosovsky, Vivek Roy, Hope S. Rugo, Sumithira Vasu, Martha Wadleigh, Peter Westervelt, and Pamela S. Becker

review . Crit Care Med 2019 ; 47 : 1637 – 1644 . 10.1097/CCM.0000000000003985 31449062 20. Tay J , Allan DS , Chatelain E , . Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell